Latest news
TG Therapeutics Earnings Call Signals BRIUMVI Surge - The Globe and MailThe Globe and Mail · Thu, 06 Aug 2026 01:06:00 GMTTG Therapeutics: BRIUMVI Revenue Jumps 64% To $227.7 Million - Pulse 2.0Pulse 2.0 · Wed, 05 Aug 2026 16:48:41 GMTTG Therapeutics' BRIUMVI sales jump 64% YoY, bo... - PluangPluang · Mon, 03 Aug 2026 21:54:27 GMTTGTX: Strong revenue growth and profitability driven by BRIUMVI, with robust liquidity and pipeline progress - TradingViewTradingView · Mon, 03 Aug 2026 21:02:19 GMTTG Therapeutics Falls Short on Q2 2026: $0.05 EPS vs $0.33 Expected - AlphaStreetAlphaStreet · Mon, 03 Aug 2026 19:53:16 GMTAlphabet Shares Jump; $98 Billion Investment Gain Skews Valuation Metric - TechStock²TechStock² · Mon, 03 Aug 2026 15:04:31 GMTTG Therapeutics reports Q2 2026 revenue ~$240M, raises 2026 BRIUMVI U.S. revenue guidance - TradingViewTradingView · Mon, 03 Aug 2026 11:23:01 GMTBRIUMVI brings in $228 million as TG Therapeutics lifts 2026 target - Stock TitanStock Titan · Mon, 03 Aug 2026 11:00:00 GMT